Picture of IDEXX Laboratories logo

IDXX IDEXX Laboratories Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual income statement for IDEXX Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2,4072,7073,2153,3673,661
Cost of Revenue
Gross Profit1,3661,5711,8892,0042,190
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses1,8542,0122,2832,4692,564
Operating Profit5536959328991,097
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes5226629038601,061
Provision for Income Taxes
Net Income After Taxes428582745679845
Minority Interest
Net Income Before Extraordinary Items
Net Income428582745679845
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income428582745679845
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS4.896.738.658.0310.1